{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T04:54:26Z","timestamp":1790916866163,"version":"4.1.0"},"reference-count":77,"publisher":"Bentham Science Publishers Ltd.","issue":"9","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CPB"],"published-print":{"date-parts":[[2026,6]]},"abstract":"<jats:sec>\n                    <jats:title\/>\n                    <jats:p>PIWI-interacting RNAs (piRNAs), a class of small non-coding RNAs originally identified\nin germ cells, are now increasingly recognized as pivotal regulators of gene expression in\nsomatic tissues, including the cardiovascular system. Cardiovascular diseases (CVDs) remain\nthe leading global cause of morbidity and mortality, yet sensitive and specific molecular biomarkers\nand effective RNA-based therapeutic targets are still lacking. However, compared to\nmicroRNAs and lncRNAs, the roles of piRNAs in CVD are only beginning to be elucidated,\nhighlighting an important knowledge gap. The objective of this review was to synthesize current\nevidence on piRNA functions in cardiovascular biology, with emphasis on disease-specific\nmechanisms and translational implications. To achieve this, we conducted a literature search in\nPubMed and Web of Science databases (2015\u20132025) using the keywords \u201cpiRNA\u201d OR \u201cPIWIinteracting\nRNA\u201d combined with \u201ccardiovascular\u201d, \u201cheart failure\u201d, \u201cischemia reperfusion\u201d,\n\u201cmyocardial infarction\u201d, \u201caortic valve\u201d, and \u201cpulmonary hypertension\u201d. This review has not only\nsummarized existing findings, but also highlighted emerging opportunities and challenges for\nadvancing piRNA-based diagnostics and therapeutics in cardiovascular medicine.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.2174\/0113892010424194251027101646","type":"journal-article","created":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T09:36:53Z","timestamp":1767951413000},"page":"1037-1045","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Rewriting the Cardiovascular Transcriptome: Emerging Roles of PIWI-Interacting RNAs as Epigenetic Modulators and Precision Biomarkers"],"prefix":"10.2174","volume":"27","author":[{"given":"Qiang","family":"Chen","sequence":"first","affiliation":[{"name":"School of Basic Medicine, Hangzhou Normal University, Hangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shanshan","family":"Li","sequence":"additional","affiliation":[{"name":"School of Medicine, Nankai University, Tianjin, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Jin","sequence":"additional","affiliation":[{"name":"School of Medicine, Nankai University, Tianjin, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"11","DOI":"10.5334\/gh.1288","volume":"19","author":"Di Cesare M.","year":"2024","unstructured":"Di Cesare M.; Perel P.; Taylor S.; Kabudula C.; Bixby H.; Gaziano T.A.; McGhie D.V.; Mwangi J.; Pervan B.; Narula J.; Pineiro D.; Pinto F.J.; The heart of the world. Glob Heart  2024,19(1),11","journal-title":"Glob Heart"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1186\/s12889-021-10429-0","volume":"21","author":"Amini M.","year":"2021","unstructured":"Amini M.; Zayeri F.; Salehi M.; Trend analysis of cardiovascular disease mortality, incidence, and mortality-to-incidence ratio: Results from global burden of disease study 2017. BMC Public Health  2021,21(1),401","journal-title":"BMC Public Health"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"2372","DOI":"10.1016\/j.jacc.2022.11.001","volume":"80","author":"Lindstrom M.","year":"2022","unstructured":"Lindstrom M.; DeCleene N.; Dorsey H.; Fuster V.; Johnson C.O.; LeGrand K.E.; Mensah G.A.; Razo C.; Stark B.; Varieur Turco J.; Roth G.A.; Global burden of cardiovascular diseases and risks collaboration, 1990-2021. J Am Coll Cardiol  2022,80(25),2372-2425","journal-title":"J Am Coll Cardiol"},{"key":"ref=4","doi-asserted-by":"publisher","DOI":"10.1007\/s10557-025-07739-5","author":"Akanda M.R.","year":"2025","unstructured":"Akanda M.R.; Sabuj M.S.S.; Salam S.M.A.; Jahan E.; Molecular interplay of gene network dynamics, epigenetic regulation, and therapeutic mapping in cardiovascular disease. Cardiovasc Drugs Ther  2025","journal-title":"Cardiovasc Drugs Ther"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"14168","DOI":"10.3390\/ijms241814168","volume":"24","author":"Bustin S.A.","year":"2023","unstructured":"Bustin S.A.; Jellinger K.A.; Advances in molecular medicine: Unravelling disease complexity and pioneering precision healthcare. Int J Mol Sci  2023,24(18),14168","journal-title":"Int J Mol Sci"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1038\/s41392-023-01399-3","volume":"8","author":"Qiu S.","year":"2023","unstructured":"Qiu S.; Cai Y.; Yao H.; Lin C.; Xie Y.; Tang S.; Zhang A.; Small molecule metabolites: Discovery of biomarkers and therapeutic targets. Signal Transduct Target Ther  2023,8(1),132","journal-title":"Signal Transduct Target Ther"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"106561","DOI":"10.4330\/wjc.v17.i7.106561","volume":"17","author":"Bokhari S.F.H.","year":"2025","unstructured":"Bokhari S.F.H.; Umais M.; Faizan Sattar S.M.; Mehboob U.; Iqbal A.; Amir M.; Bakht D.; Ali K.; Hasan A.H.; Javed M.A.; Dost W.; Novel cardiac biomarkers and multiple-marker approach in the early detection, prognosis, and risk stratification of cardiac diseases. World J Cardiol  2025,17(7),106561","journal-title":"World J Cardiol"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1016\/j.molmed.2014.09.002","volume":"20","author":"Atianand M.K.","year":"2014","unstructured":"Atianand M.K.; Fitzgerald K.A.; Long non-coding RNAs and control of gene expression in the immune system. Trends Mol Med  2014,20(11),623-631","journal-title":"Trends Mol Med"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1007\/s11011-021-00739-y","volume":"36","author":"Bhatti G.K.","year":"2021","unstructured":"Bhatti G.K.; Khullar N.; Sidhu I.S.; Navik U.S.; Reddy A.P.; Reddy P.H.; Bhatti J.S.; Emerging role of non\u2010coding RNA in health and disease. Metab Brain Dis  2021,36(6),1119-1134","journal-title":"Metab Brain Dis"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"33767","DOI":"10.1016\/j.heliyon.2024.e33767","volume":"10","author":"Ahmadi Asouri S.","year":"2024","unstructured":"Ahmadi Asouri S.; Aghadavood E.; Mirzaei H.; Abaspour A.; Esmaeil Shahaboddin M.; PIWI-interacting RNAs (piRNAs) as emerging biomarkers and therapeutic targets in biliary tract cancers: A comprehensive review. Heliyon  2024,10(13),33767","journal-title":"Heliyon"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"975","DOI":"10.2217\/epi.15.37","volume":"7","author":"Assump\u00e7\u00e3o C.B.","year":"2015","unstructured":"Assump\u00e7\u00e3o C.B.; Calcagno D.Q.; Ara\u00fajo T.M.T.; Batista dos Santos S.E.; Ribeiro dos Santos \u00c2.K.C.; Riggins G.J.; Burbano R.R.; Assump\u00e7\u00e3o P.P.; The role of piRNA and its potential clinical implications in cancer. Epigenomics  2015,7(6),975-984","journal-title":"Epigenomics"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/s12943-023-01749-3","volume":"22","author":"Zhang Q.","year":"2023","unstructured":"Zhang Q.; Zhu Y.; Cao X.; Tan W.; Yu J.; Lu Y.; Kang R.; Wang X.; Li E.; The epigenetic regulatory mechanism of PIWI\/piRNAs in human cancers. Mol Cancer  2023,22(1),45","journal-title":"Mol Cancer"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"101342","DOI":"10.1016\/j.gendis.2024.101342","volume":"12","author":"Bai H.","year":"2025","unstructured":"Bai H.; Meng F.; Ke K.; Fang L.; Xu W.; Huang H.; Liang X.; Li W.; Zeng F.; Chen C.; The significance of small noncoding RNAs in the pathogenesis of cardiovascular diseases. Genes Dis  2025,12(4),101342","journal-title":"Genes Dis"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.omtn.2020.05.023","volume":"21","author":"Wu X.","year":"2020","unstructured":"Wu X.; Pan Y.; Fang Y.; Zhang J.; Xie M.; Yang F.; Yu T.; Ma P.; Li W.; Shu Y.; The biogenesis and functions of piRNAs in human diseases. Mol Ther Nucleic Acids  2020,21,108-120","journal-title":"Mol Ther Nucleic Acids"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"70012","DOI":"10.1002\/wrna.70012","volume":"16","author":"Dudzik J.","year":"2025","unstructured":"Dudzik J.; Czechowicz P.; Wi\u0119ch-Wal\u00f3w A.; S\u0142awski J.; Collawn J.F.; Bartoszewski R.; PiRNAs, piRNA\u2010Like, and PIWI proteins in somatic cells: From genetic regulation to disease mechanisms. Wiley Interdiscip Rev RNA  2025,16(2),70012","journal-title":"Wiley Interdiscip Rev RNA"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1093\/eurheartj\/ehab757","volume":"43","author":"Kraler S.","year":"2022","unstructured":"Kraler S.; Blaser M.C.; Aikawa E.; Camici G.G.; L\u00fcscher T.F.; Calcific aortic valve disease: From molecular and cellular mechanisms to medical therapy. Eur Heart J  2022,43(7),683-697","journal-title":"Eur Heart J"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.phrs.2018.08.020","volume":"136","author":"Myasoedova V.A.","year":"2018","unstructured":"Myasoedova V.A.; Ravani A.L.; Frigerio B.; Valerio V.; Moschetta D.; Songia P.; Poggio P.; Novel pharmacological targets for calcific aortic valve disease: Prevention and treatments. Pharmacol Res  2018,136,74-82","journal-title":"Pharmacol Res"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"1665","DOI":"10.1093\/eurheartj\/ehac050","volume":"43","author":"Kraler S.","year":"2022","unstructured":"Kraler S.; Garg V.; Akhmedov A.; Calcific aortic valve disease: Novel insights into nitric oxide signalling. Eur Heart J  2022,43(17),1665-1667","journal-title":"Eur Heart J"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"12710","DOI":"10.18632\/aging.202942","volume":"13","author":"Yi B.","year":"2021","unstructured":"Yi B.; Zeng W.; Lv L.; Hua P.; Changing epidemiology of calcific aortic valve disease: 30-year trends of incidence, prevalence, and deaths across 204 countries and territories. Aging (Albany NY)  2021,13(9),12710-12732","journal-title":"Aging (Albany NY)"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"2852","DOI":"10.1016\/j.jacc.2014.04.018","volume":"63","author":"Coffey S.","year":"2014","unstructured":"Coffey S.; Cox B.; Williams M.J.A.; The prevalence, incidence, progression, and risks of aortic valve sclerosis: A systematic review and meta-analysis. J Am Coll Cardiol  2014,63(25),2852-2861","journal-title":"J Am Coll Cardiol"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1056\/NEJM199907153410302","volume":"341","author":"Otto C.M.","year":"1999","unstructured":"Otto C.M.; Lind B.K.; Kitzman D.W.; Gersh B.J.; Siscovick D.S.; Association of aortic-valve sclerosis with cardiovascular mortality and morbidity in the elderly. N Engl J Med  1999,341(3),142-147","journal-title":"N Engl J Med"},{"key":"ref=22","first-page":"76","volume":"15","author":"Grigorios T.","year":"2018","unstructured":"Grigorios T.; Stefanos D.; Athanasios M.; Ioanna K.; Stylianos A.; Periklis D.; George H.; Transcatheter versus surgical aortic valve replacement in severe, symptomatic aortic stenosis. J Geriatr Cardiol  2018,15(1),76-85","journal-title":"J Geriatr Cardiol"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"1312","DOI":"10.1016\/S0140-6736(16)00586-9","volume":"387","author":"Bonow R.O.","year":"2016","unstructured":"Bonow R.O.; Leon M.B.; Doshi D.; Moat N.; Management strategies and future challenges for aortic valve disease. Lancet  2016,387(10025),1312-1323","journal-title":"Lancet"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1146\/annurev-med-101615-020427","volume":"68","author":"Eleid M.F.","year":"2017","unstructured":"Eleid M.F.; Holmes D.R.; Transcatheter aortic valve replacement: State of the art and future directions. Annu Rev Med  2017,68(1),15-28","journal-title":"Annu Rev Med"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1161\/CIRCRESAHA.118.313864","volume":"124","author":"Tsimikas S.","year":"2019","unstructured":"Tsimikas S.; Potential causality and emerging medical therapies for lipoprotein(a) and its associated oxidized phospholipids in calcific aortic valve stenosis. Circ Res  2019,124(3),405-415","journal-title":"Circ Res"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"1578","DOI":"10.1161\/CIRCULATIONAHA.123.065213","volume":"149","author":"Han D.","year":"2024","unstructured":"Han D.; Zhou T.; Li L.; Ma Y.; Chen S.; Yang C.; Ma N.; Song M.; Zhang S.; Wu J.; Cao F.; Wang Y.; AVCAPIR: A novel procalcific piwi-interacting rna in calcific aortic valve disease. Circulation  2024,149(20),1578-1597","journal-title":"Circulation"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"12666","DOI":"10.1111\/jpi.12666","volume":"69","author":"Wang Y.","year":"2020","unstructured":"Wang Y.; Han D.; Zhou T.; Zhang J.; Liu C.; Cao F.; Dong N.; Melatonin ameliorates aortic valve calcification via the regulation of circular RNA CircRIC3\/miR\u2010204\u20105p\/DPP4 signaling in valvular interstitial cells. J Pineal Res  2020,69(2),12666","journal-title":"J Pineal Res"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1093\/cvr\/cvx180","volume":"114","author":"Yu C.","year":"2018","unstructured":"Yu C.; Li L.; Xie F.; Guo S.; Liu F.; Dong N.; Wang Y.; LncRNA TUG1 sponges miR-204-5p to promote osteoblast differentiation through upregulating Runx2 in aortic valve calcification. Cardiovasc Res  2018,114(1),168-179","journal-title":"Cardiovasc Res"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1016\/j.ijcard.2017.05.037","volume":"243","author":"Xiao X.","year":"2017","unstructured":"Xiao X.; Zhou T.; Guo S.; Guo C.; Zhang Q.; Dong N.; Wang Y.; LncRNA MALAT1 sponges miR-204 to promote osteoblast differentiation of human aortic valve interstitial cells through up-regulating Smad4. Int J Cardiol  2017,243,404-412","journal-title":"Int J Cardiol"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"167354","DOI":"10.1016\/j.bbadis.2024.167354","volume":"1870","author":"Zhao Y.","year":"2024","unstructured":"Zhao Y.; Ding W.; Cai Y.; Li Q.; Zhang W.; Bai Y.; Zhang Y.; Xu Q.; Feng Z.; The m6A eraser FTO suppresses ferroptosis via mediating ACSL4 in LPS-induced macrophage inflammation. Biochim Biophys Acta Mol Basis Dis  2024,1870(7),167354","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1016\/j.atherosclerosis.2014.05.933","volume":"235","author":"Syv\u00e4ranta S.","year":"2014","unstructured":"Syv\u00e4ranta S.; Alanne-Kinnunen M.; \u00d6\u00f6rni K.; Oksjoki R.; Kupari M.; Kovanen P.T.; Helske-Suihko S.; Potential pathological roles for oxidized low-density lipoprotein and scavenger receptors SR-AI, CD36, and LOX-1 in aortic valve stenosis. Atherosclerosis  2014,235(2),398-407","journal-title":"Atherosclerosis"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1016\/j.jacbts.2020.05.004","volume":"5","author":"Perrot N.","year":"2020","unstructured":"Perrot N.; Valerio V.; Moschetta D.; Boekholdt S.M.; Dina C.; Chen H.Y.; Abner E.; Martinsson A.; Manikpurage H.D.; Rigade S.; Capoulade R.; Mass E.; Clavel M.A.; Le Tourneau T.; Messika-Zeitoun D.; Wareham N.J.; Engert J.C.; Polvani G.; Pibarot P.; Esko T.; Smith J.G.; Mathieu P.; Thanassoulis G.; Schott J.J.; Boss\u00e9 Y.; Camera M.; Th\u00e9riault S.; Poggio P.; Arsenault B.J.; Genetic and in vitro inhibition of PCSK9 and calcific aortic valve stenosis. JACC Basic Transl Sci  2020,5(7),649-661","journal-title":"JACC Basic Transl Sci"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"1750","DOI":"10.1093\/eurheartj\/ehr254","volume":"33","year":"2012","unstructured":"The survival of patients with heart failure with preserved or reduced left ventricular ejection fraction: An individual patient data meta-analysis. Eur Heart J  2012,33(14),1750-1757","journal-title":"Eur Heart J"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.1161\/CIRCRESAHA.121.318172","volume":"128","author":"Roger V.L.","year":"2021","unstructured":"Roger V.L.; Epidemiology of heart failure. Circ Res  2021,128(10),1421-1434","journal-title":"Circ Res"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1038\/nrcardio.2011.172","volume":"9","author":"Koitabashi N.","year":"2012","unstructured":"Koitabashi N.; Kass D.A.; Reverse remodeling in heart failure\u2014mechanisms and therapeutic opportunities. Nat Rev Cardiol  2012,9(3),147-157","journal-title":"Nat Rev Cardiol"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1016\/j.yjmcc.2019.03.010","volume":"129","author":"Dorn L.E.","year":"2019","unstructured":"Dorn L.E.; Tual-Chalot S.; Stellos K.; Accornero F.; RNA epigenetics and cardiovascular diseases. J Mol Cell Cardiol  2019,129,272-280","journal-title":"J Mol Cell Cardiol"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"2668","DOI":"10.1161\/CIRCULATIONAHA.118.035832","volume":"139","author":"Ponnusamy M.","year":"2019","unstructured":"Ponnusamy M.; Liu F.; Zhang Y.H.; Li R.B.; Zhai M.; Liu F.; Zhou L.Y.; Liu C.Y.; Yan K.W.; Dong Y.H.; Wang M.; Qian L.L.; Shan C.; Xu S.; Wang Q.; Zhang Y.H.; Li P.F.; Zhang J.; Wang K.; Long Noncoding RNA CPR (Cardiomyocyte Proliferation Regulator) Regulates Cardiomyocyte Proliferation and Cardiac Repair. Circulation  2019,139(23),2668-2684","journal-title":"Circulation"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1093\/eurheartj\/ehu180","volume":"36","author":"Ounzain S.","year":"2015","unstructured":"Ounzain S.; Micheletti R.; Beckmann T.; Schroen B.; Alexanian M.; Pezzuto I.; Crippa S.; Nemir M.; Sarre A.; Johnson R.; Dauvillier J.; Burdet F.; Ibberson M.; Guig\u00f3 R.; Xenarios I.; Heymans S.; Pedrazzini T.; Genome-wide profiling of the cardiac transcriptome after myocardial infarction identifies novel heart-specific long non-coding RNAs. Eur Heart J  2015,36(6),353-368","journal-title":"Eur Heart J"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"166","DOI":"10.3390\/jcdd10040166","volume":"10","author":"Kawaguchi S.","year":"2023","unstructured":"Kawaguchi S.; Moukette B.; Hayasaka T.; Haskell A.K.; Mah J.; Sep\u00falveda M.N.; Tang Y.; Kim I.; Noncoding RNAs as key regulators for cardiac development and cardiovascular diseases. J Cardiovasc Dev Dis  2023,10(4),166","journal-title":"J Cardiovasc Dev Dis"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1038\/s41556-020-0576-y","volume":"22","author":"Gao X.Q.","year":"2020","unstructured":"Gao X.Q.; Zhang Y.H.; Liu F.; Ponnusamy M.; Zhao X.M.; Zhou L.Y.; Zhai M.; Liu C.Y.; Li X.M.; Wang M.; Shan C.; Shan P.P.; Wang Y.; Dong Y.H.; Qian L.L.; Yu T.; Ju J.; Wang T.; Wang K.; Chen X.Z.; Wang Y.H.; Zhang J.; Li P.F.; Wang K.; The piRNA CHAPIR regulates cardiac hypertrophy by controlling METTL3-dependent N6-methyladenosine methylation of Parp10 mRNA. Nat Cell Biol  2020,22(11),1319-1331","journal-title":"Nat Cell Biol"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"1982","DOI":"10.1038\/sj.onc.1208410","volume":"24","author":"Yu M.","year":"2005","unstructured":"Yu M.; Schreek S.; Cerni C.; Schamberger C.; Lesniewicz K.; Poreba E.; Vervoorts J.; Walsemann G.; Gr\u00f6tzinger J.; Kremmer E.; Mehraein Y.; Mertsching J.; Kraft R.; Austen M.; L\u00fcscher-Firzlaff J.; L\u00fcscher B.; PARP-10, a novel Myc-interacting protein with poly(ADP-ribose) polymerase activity, inhibits transformation. Oncogene  2005,24(12),1982-1993","journal-title":"Oncogene"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"15201","DOI":"10.1074\/jbc.M506745200","volume":"281","author":"Chou H.Y.E.","year":"2006","unstructured":"Chou H.Y.E.; Chou H.T.; Lee S.C.; CDK-dependent activation of poly(ADP-ribose) polymerase member 10 (PARP10). J Biol Chem  2006,281(22),15201-15207","journal-title":"J Biol Chem"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.molcel.2008.08.009","volume":"32","author":"Kleine H.","year":"2008","unstructured":"Kleine H.; Poreba E.; Lesniewicz K.; Hassa P.O.; Hottiger M.O.; Litchfield D.W.; Shilton B.H.; L\u00fcscher B.; Substrate-assisted catalysis by PARP10 limits its activity to mono-ADP-ribosylation. Mol Cell  2008,32(1),57-69","journal-title":"Mol Cell"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1161\/01.RES.0000018952.70505.F1","volume":"90","author":"Hardt S.E.","year":"2002","unstructured":"Hardt S.E.; Sadoshima J.; Glycogen synthase kinase-3beta: A novel regulator of cardiac hypertrophy and development. Circ Res  2002,90(10),1055-1063","journal-title":"Circ Res"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"S137","DOI":"10.1038\/sj.bjp.0707659","volume":"153","author":"Sugden P.H.","year":"2008","unstructured":"Sugden P.H.; Fuller S.J.; Weiss S.C.; Clerk A.; Glycogen synthase kinase 3 (GSK3) in the heart: A point of integration in hypertrophic signalling and a therapeutic target? A critical analysis. Br J Pharmacol  2008,153(Suppl 1),S137-S153","journal-title":"Br J Pharmacol"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.trsl.2024.07.003","volume":"273","author":"Niro F.","year":"2024","unstructured":"Niro F.; Fernandes S.; Cassani M.; Apostolico M.; Oliver-De La Cruz J.; Pereira-Sousa D.; Pagliari S.; Vinarsky V.; Zdr\u00e1hal Z.; Potesil D.; Pustka V.; Pompilio G.; Sommariva E.; Rovina D.; Maione A.S.; Bersanini L.; Becker M.; Rasponi M.; Forte G.; Fibrotic extracellular matrix impacts cardiomyocyte phenotype and function in an iPSC-derived isogenic model of cardiac fibrosis. Transl Res  2024,273,58-77","journal-title":"Transl Res"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1007\/s00018-013-1349-6","volume":"71","author":"Kong P.","year":"2014","unstructured":"Kong P.; Christia P.; Frangogiannis N.G.; The pathogenesis of cardiac fibrosis. Cell Mol Life Sci  2014,71(4),549-574","journal-title":"Cell Mol Life Sci"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"2617","DOI":"10.3390\/ijms23052617","volume":"23","author":"Maruyama K.","year":"2022","unstructured":"Maruyama K.; Imanaka-Yoshida K.; The pathogenesis of cardiac fibrosis: A review of recent progress. Int J Mol Sci  2022,23(5),2617","journal-title":"Int J Mol Sci"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"791931","DOI":"10.3389\/fmmed.2021.791931","volume":"1","author":"Cheang I.","year":"2022","unstructured":"Cheang I.; Zhu Q.; Liao S.; Li X.; Current understanding of pirna in cardiovascular diseases. Front Mol Med  2022,1,791931","journal-title":"Front Mol Med"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"1895","DOI":"10.3390\/diagnostics13111895","volume":"13","author":"Liman\u00f3wka P.","year":"2023","unstructured":"Liman\u00f3wka P.; Ochman B.; \u015awi\u0119tochowska E.; PiRNA obtained through liquid biopsy as a possible cancer biomarker. Diagnostics  2023,13(11),1895","journal-title":"Diagnostics"},{"key":"ref=51","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.medj.2023.12.007","volume":"5","author":"Heusch G.","year":"2024","unstructured":"Heusch G.; Myocardial ischemia\/reperfusion: Translational pathophysiology of ischemic heart disease. Med (N Y)  2024,5(1),10-31","journal-title":"Med (N Y)"},{"key":"ref=52","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1038\/s41392-023-01688-x","volume":"9","author":"Zhang M.","year":"2024","unstructured":"Zhang M.; Liu Q.; Meng H.; Duan H.; Liu X.; Wu J.; Gao F.; Wang S.; Tan R.; Yuan J.; Ischemia-reperfusion injury: Molecular mechanisms and therapeutic targets. Signal Transduct Target Ther  2024,9(1),12","journal-title":"Signal Transduct Target Ther"},{"key":"ref=53","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.cca.2021.03.011","volume":"518","author":"Zeng Q.","year":"2021","unstructured":"Zeng Q.; Cai J.; Wan H.; Zhao S.; Tan Y.; Zhang C.; Qu S.; PIWI-interacting RNAs and PIWI proteins in diabetes and cardiovascular disease: Molecular pathogenesis and role as biomarkers. Clin Chim Acta  2021,518,33-37","journal-title":"Clin Chim Acta"},{"key":"ref=54","doi-asserted-by":"publisher","first-page":"2106058","DOI":"10.1002\/advs.202106058","volume":"9","author":"Wang K.","year":"2022","unstructured":"Wang K.; Zhou L.Y.; Liu F.; Lin L.; Ju J.; Tian P.C.; Liu C.Y.; Li X.M.; Chen X.Z.; Wang T.; Wang F.; Wang S.C.; Zhang J.; Zhang Y.H.; Tian J.W.; Wang K.; PIWI\u2010interacting RNA HAAPIR regulates cardiomyocyte death after myocardial infarction by promoting NAT10\u2010mediated ac 4 C acetylation of Tfec mRNA. Adv Sci  2022,9(8),2106058","journal-title":"Adv Sci"},{"key":"ref=55","doi-asserted-by":"publisher","first-page":"1872","DOI":"10.1016\/j.cell.2018.10.030","volume":"175","author":"Arango D.","year":"2018","unstructured":"Arango D.; Sturgill D.; Alhusaini N.; Dillman A.A.; Sweet T.J.; Hanson G.; Hosogane M.; Sinclair W.R.; Nanan K.K.; Mandler M.D.; Fox S.D.; Zengeya T.T.; Andresson T.; Meier J.L.; Coller J.; Oberdoerffer S.; Acetylation of cytidine in mRNA promotes translation efficiency. Cell  2018,175(7),1872-1886.e24","journal-title":"Cell"},{"key":"ref=56","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/bs.ircmb.2019.12.006","volume":"353","author":"Dion\u00edsio P.A.","year":"2020","unstructured":"Dion\u00edsio P.A.; Amaral J.D.; Rodrigues C.M.P.; Molecular mechanisms of necroptosis and relevance for neurodegenerative diseases. Int Rev Cell Mol Biol  2020,353,31-82","journal-title":"Int Rev Cell Mol Biol"},{"key":"ref=57","doi-asserted-by":"publisher","first-page":"173999","DOI":"10.1016\/j.ejphar.2021.173999","volume":"898","author":"Tu H.","year":"2021","unstructured":"Tu H.; Zhou Y.J.; Tang L.J.; Xiong X.M.; Zhang X.J.; Ali Sheikh M.S.; Zhang J.J.; Luo X.J.; Yuan C.; Peng J.; Combination of ponatinib with deferoxamine synergistically mitigates ischemic heart injury via simultaneous prevention of necroptosis and ferroptosis. Eur J Pharmacol  2021,898,173999","journal-title":"Eur J Pharmacol"},{"key":"ref=58","doi-asserted-by":"publisher","first-page":"2304329","DOI":"10.1002\/advs.202304329","volume":"10","author":"Wang K.","year":"2023","unstructured":"Wang K.; Li F.H.; Zhou L.Y.; Zhao X.M.; Gao X.Q.; Liu C.Y.; Li X.M.; Chen X.Z.; Zhao Y.; Cheng X.L.; Wang R.Q.; Li R.F.; Zhang Y.H.; Gao F.; Tian J.W.; Wang K.; HNEAP regulates necroptosis of cardiomyocytes by suppressing the m 5 C methylation of Atf7 mRNA. Adv Sci  2023,10(34),2304329","journal-title":"Adv Sci"},{"key":"ref=59","doi-asserted-by":"publisher","first-page":"1352","DOI":"10.3724\/abbs.2024024","volume":"56","author":"Chi H.","year":"2024","unstructured":"Chi H.; Chai Y.; Ma L.; Wang Y.; Wu Q.; Wang L.; Zhai J.; Ma F.; Tian Y.; Qi N.; Peng J.; Fu Y.; Yang X.; Huang H.; Ma S.; The mechanism by which piR-000699 targets SLC39A14 regulates ferroptosis in aging myocardial A3B2 pi6 ischemia\/reperfusion injury. Acta Biochim Biophys Sin  2024,56(9),1352-1364","journal-title":"Acta Biochim Biophys Sin"},{"key":"ref=60","doi-asserted-by":"publisher","first-page":"183","DOI":"10.3724\/abbs.2023019","volume":"55","author":"Li C.","year":"2023","unstructured":"Li C.; Zhu X.; Chen J.; Xie X.; Liang S.; Liu X.; Gong Q.; Guo J.; Multifaceted role of ferroptosis in cardiovascular disease. Acta Biochim Biophys Sin  2023,55(2),183-193","journal-title":"Acta Biochim Biophys Sin"},{"key":"ref=61","doi-asserted-by":"publisher","first-page":"2215","DOI":"10.1016\/j.molcel.2022.03.022","volume":"82","author":"Liang D.","year":"2022","unstructured":"Liang D.; Minikes A.M.; Jiang X.; Ferroptosis at the intersection of lipid metabolism and cellular signaling. Mol Cell  2022,82(12),2215-2227","journal-title":"Mol Cell"},{"key":"ref=62","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.1161\/CIRCULATIONAHA.122.060257","volume":"147","author":"Cai W.","year":"2023","unstructured":"Cai W.; Liu L.; Shi X.; Liu Y.; Wang J.; Fang X.; Chen Z.; Ai D.; Zhu Y.; Zhang X.; Alox15\/15-HpETE aggravates myocardial ischemia-reperfusion injury by promoting cardiomyocyte ferroptosis. Circulation  2023,147(19),1444-1460","journal-title":"Circulation"},{"key":"ref=63","doi-asserted-by":"publisher","first-page":"666","DOI":"10.3390\/biom9110666","volume":"9","author":"Lipps C.","year":"2019","unstructured":"Lipps C.; Northe P.; Figueiredo R.; Rohde M.; Brahmer A.; Kr\u00e4mer-Albers E.M.; Liebetrau C.; Wiedenroth C.B.; Mayer E.; Kriechbaum S.D.; D\u00f6rr O.; Nef H.; Hamm C.W.; Keller T.; Troidl C.; Non-invasive approach for evaluation of pulmonary hypertension using extracellular vesicle-associated small non-coding RNA. Biomolecules  2019,9(11),666","journal-title":"Biomolecules"},{"key":"ref=64","doi-asserted-by":"publisher","first-page":"106932","DOI":"10.1016\/j.phrs.2023.106932","volume":"196","author":"Li M.","year":"2023","unstructured":"Li M.; Li G.; Yang Y.; Zong J.; Fu X.; Htet A.L.H.; Li X.; Li T.; Wang J.; Yu T.; piRNA-823 is a novel potential therapeutic target in aortic dissection. Pharmacol Res  2023,196,106932","journal-title":"Pharmacol Res"},{"key":"ref=65","doi-asserted-by":"publisher","first-page":"5260","DOI":"10.1111\/jcmm.15179","volume":"24","author":"Ma C.","year":"2020","unstructured":"Ma C.; Zhang L.; Wang X.; He S.; Bai J.; Li Q.; Zhang M.; Zhang C.; Yu X.; Zhang J.; Xin W.; Li Y.; Zhu D.; piRNA\u201063076 contributes to pulmonary arterial smooth muscle cell proliferation through acyl\u2010CoA dehydrogenase. J Cell Mol Med  2020,24(9),5260-5273","journal-title":"J Cell Mol Med"},{"key":"ref=66","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1016\/j.jjcc.2023.06.015","volume":"82","author":"Huang Y.","year":"2023","unstructured":"Huang Y.; Li Y.; Zhang K.; Xu J.; Li P.; Yan X.; Sun K.; Expression and diagnostic value of PIWI-interacting RNA by serum in acute myocardial infarction. J Cardiol  2023,82(6),441-447","journal-title":"J Cardiol"},{"key":"ref=67","doi-asserted-by":"publisher","DOI":"10.1038\/s41596-025-01158-4","author":"Shi J.","year":"2025","unstructured":"Shi J.; Zhang Y.; Li Y.; Zhang L.; Zhang X.; Yan M.; Chen Q.; Zhang Y.; Optimized identification and characterization of small RNAs with PANDORA-seq. Nat Protoc  2025","journal-title":"Nat Protoc"},{"key":"ref=68","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1097\/MS9.0000000000001473","volume":"86","author":"Li J.","year":"2024","unstructured":"Li J.; Lin A.; Jiang R.; Chen P.; Xu C.; Hou Y.; Exosomes-mediated drug delivery for the treatment of myocardial injury. Ann Med Surg  2024,86(1),292-299","journal-title":"Ann Med Surg"},{"key":"ref=69","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1038\/s41698-024-00556-3","volume":"8","author":"Corvigno S.","year":"2024","unstructured":"Corvigno S.; Liu Y.; Bayraktar E.; Stur E.; Bayram N.N.; Ahumada A.L.; Nagaraju S.; Rodriguez-Aguayo C.; Chen H.; Vu T.C.; Wen Y.; Liang H.; Zhao L.; Lee S.; Lopez-Berestein G.; Sood A.K.; Enhanced plant-derived vesicles for nucleotide delivery for cancer therapy. NPJ Precis Oncol  2024,8(1),86","journal-title":"NPJ Precis Oncol"},{"key":"ref=70","doi-asserted-by":"publisher","first-page":"1770","DOI":"10.1002\/ctm2.1770","volume":"14","author":"Li B.","year":"2024","unstructured":"Li B.; Wang K.; Cheng W.; Fang B.; Li Y.H.; Yang S.M.; Zhang M.H.; Wang Y.H.; Wang K.; Recent advances of PIWI\u2010interacting RNA in cardiovascular diseases. Clin Transl Med  2024,14(8),1770","journal-title":"Clin Transl Med"},{"key":"ref=71","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.atherosclerosis.2022.12.003","volume":"374","author":"Saenz-Pipaon G.","year":"2023","unstructured":"Saenz-Pipaon G.; Dichek D.A.; Targeting and delivery of microRNA-targeting antisense oligonucleotides in cardiovascular diseases. Atherosclerosis  2023,374,44-54","journal-title":"Atherosclerosis"},{"key":"ref=72","doi-asserted-by":"publisher","first-page":"H991","DOI":"10.1152\/ajpheart.00833.2024","volume":"328","author":"Shivam P.","year":"2025","unstructured":"Shivam P.; Ball D.; Cooley A.; Osi I.; Rayford K.J.; Gonzalez S.B.; Edwards A.D.; McIntosh A.R.; Devaughn J.; Pugh-Brown J.P.; Misra S.; Kirabo A.; Ramesh A.; Lindsey M.L.; Sakwe A.M.; Gaye A.; Hinton A.; Martin P.M.; Nde P.N.; Regulatory roles of PIWI-interacting RNAs in cardiovascular disease. Am J Physiol Heart Circ Physiol  2025,328(4),H991-H1004","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"ref=73","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1016\/j.bbrc.2018.03.227","volume":"499","author":"Kim H.","year":"2018","unstructured":"Kim H.; Yun N.; Mun D.; Kang J.Y.; Lee S.H.; Park H.; Park H.; Joung B.; Cardiac-specific delivery by cardiac tissue-targeting peptide-expressing exosomes. Biochem Biophys Res Commun  2018,499(4),803-808","journal-title":"Biochem Biophys Res Commun"},{"key":"ref=74","first-page":"7952","volume":"22","author":"Yang J.","year":"2018","unstructured":"Yang J.; Xue F.T.; Li Y.Y.; Liu W.; Zhang S.; Exosomal piRNA sequencing reveals differences between heart failure and healthy patients. Eur Rev Med Pharmacol Sci  2018,22(22),7952-7961","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"ref=75","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1016\/j.hlc.2016.02.015","volume":"25","author":"Rajan K.S.","year":"2016","unstructured":"Rajan K.S.; Velmurugan G.; Gopal P.; Ramprasath T.; Babu D.D.V.; Krithika S.; Jenifer Y.C.; Freddy A.; William G.; Kalpana K.; Ramasamy S.; Abundant and altered expression of PIWI-interacting RNAs during cardiac hypertrophy. Heart Lung Circ  2016,25(10),1013-1020","journal-title":"Heart Lung Circ"},{"key":"ref=76","doi-asserted-by":"publisher","first-page":"1352","DOI":"10.3724\/abbs.2024024","volume":"56","author":"Chi H.","year":"2024","unstructured":"Chi H.; Chai Y.; Ma L.; Wang Y.; Wu Q.; Wang L.; The mechanism by which piR-000699 targets SLC39A14 regulates ferroptosis in aging myocardial ischemia\/reperfusion injury. Acta Biochim Biophys Sin  2024,56(9),1352-1364","journal-title":"Acta Biochim Biophys Sin"},{"key":"ref=77","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.biocel.2016.04.012","volume":"76","author":"Vella S.","year":"2016","unstructured":"Vella S.; Gallo A.; Lo Nigro A.; Galvagno D.; Raffa G.M.; Pilato M.; Conaldi P.G.; PIWI-interacting RNA (piRNA) signatures in human cardiac progenitor cells. Int J Biochem Cell Biol  2016,76,1-11","journal-title":"Int J Biochem Cell Biol"}],"container-title":["Current Pharmaceutical Biotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0113892010424194251027101646","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/249126\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0113892010424194251027101646","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T04:07:14Z","timestamp":1790914034000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/249126\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":77,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/0113892010424194251027101646","relation":{},"ISSN":["1389-2010"],"issn-type":[{"value":"1389-2010","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Double blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2025-07-10","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-09-09","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-09-19","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-09-10","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}